225 related articles for article (PubMed ID: 20876084)
1. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy.
Watanabe K; Arumugam S; Sreedhar R; Thandavarayan RA; Nakamura T; Nakamura M; Harima M; Yoneyama H; Suzuki K
Cell Signal; 2015 Jul; 27(7):1517-24. PubMed ID: 25778904
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.
Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
Life Sci; 2012 Feb; 90(7-8):289-300. PubMed ID: 22210452
[TBL] [Abstract][Full Text] [Related]
6. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.
Sukumaran V; Watanabe K; Veeraveedu PT; Gurusamy N; Ma M; Thandavarayan RA; Lakshmanan AP; Yamaguchi K; Suzuki K; Kodama M
Int J Biol Sci; 2011 Feb; 7(2):154-67. PubMed ID: 21383952
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis.
Nimata M; Kishimoto C; Yuan Z; Shioji K
Mol Cell Biochem; 2004 Apr; 259(1-2):217-22. PubMed ID: 15124927
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y
Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640
[TBL] [Abstract][Full Text] [Related]
13. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
15. Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
Yuan Z; Nimata M; Okabe TA; Shioji K; Hasegawa K; Kita T; Kishimoto C
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1147-52. PubMed ID: 15879491
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
17. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Eur J Pharmacol; 2008 Feb; 581(1-2):121-31. PubMed ID: 18154949
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis.
Liu X; Zhu X; Wang A; Fan H; Yuan H
Int J Cardiol; 2009 Nov; 137(3):282-8. PubMed ID: 19896742
[TBL] [Abstract][Full Text] [Related]
19. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
Kano S; Satoh K; Kaneta S; Ichihara K
Pharmacology; 2008; 82(1):22-9. PubMed ID: 18434761
[TBL] [Abstract][Full Text] [Related]
20. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
